33.30
3.84%
-1.20
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RXST Giù?
Forum
Previsione
Precedente Chiudi:
$34.50
Aprire:
$34.36
Volume 24 ore:
81,642
Relative Volume:
0.14
Capitalizzazione di mercato:
$1.39B
Reddito:
$115.18M
Utile/perdita netta:
$-36.77M
Rapporto P/E:
-32.97
EPS:
-1.01
Flusso di cassa netto:
$-35.35M
1 W Prestazione:
-7.43%
1M Prestazione:
-15.30%
6M Prestazione:
-35.09%
1 anno Prestazione:
-28.88%
Rxsight Inc Stock (RXST) Company Profile
Nome
Rxsight Inc
Settore
Industria
Telefono
949-521-7822
Indirizzo
100 COLUMBIA STREET, ALISO VIEJO
Confronta RXST con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
RXST
Rxsight Inc
|
33.30 | 1.39B | 115.18M | -36.77M | -35.35M | -1.01 |
ABT
Abbott Laboratories
|
112.86 | 196.55B | 41.22B | 5.77B | 6.49B | 3.29 |
BSX
Boston Scientific Corp
|
95.91 | 141.03B | 15.91B | 1.79B | 1.89B | 1.21 |
SYK
Stryker Corp
|
366.80 | 138.80B | 21.97B | 3.59B | 3.21B | 9.33 |
MDT
Medtronic Plc
|
81.54 | 106.02B | 33.00B | 4.29B | 5.50B | 3.27 |
EW
Edwards Lifesciences Corp
|
73.42 | 43.73B | 6.60B | 4.16B | 490.10M | 6.93 |
Rxsight Inc Stock (RXST) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2024-12-20 | Downgrade | Stifel | Buy → Hold |
2024-12-11 | Downgrade | Wells Fargo | Overweight → Equal Weight |
2024-12-06 | Iniziato | UBS | Buy |
2024-10-29 | Iniziato | Jefferies | Buy |
2024-08-20 | Reiterato | Needham | Buy |
2024-08-06 | Reiterato | Needham | Buy |
2024-05-07 | Reiterato | BTIG Research | Buy |
2023-12-13 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
2023-12-12 | Iniziato | Stifel | Buy |
2023-12-04 | Iniziato | Morgan Stanley | Overweight |
2023-04-13 | Iniziato | Oppenheimer | Outperform |
2022-12-12 | Downgrade | Wells Fargo | Overweight → Equal Weight |
2022-04-08 | Iniziato | Needham | Buy |
Mostra tutto
Rxsight Inc Borsa (RXST) Ultime notizie
How the (RXST) price action is used to our Advantage - Stock Traders Daily
RxSight, Inc. (NASDAQ:RXST) institutional owners may be pleased with recent gains after 2.8% loss over the past year - Simply Wall St
RxSight, Inc. To Present At The J.P. Morgan Healthcare Conference - Barchart
RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference - The Manila Times
RxSight (NASDAQ:RXST) Hits New 1-Year LowHere's Why - MarketBeat
Trading (RXST) With Integrated Risk Controls - Stock Traders Daily
Geode Capital Management LLC Raises Stock Holdings in RxSight, Inc. (NASDAQ:RXST) - Defense World
RxSight, Inc. (NASDAQ:RXST) Shares Purchased by Geode Capital Management LLC - MarketBeat
Barclays PLC Acquires 46,783 Shares of RxSight, Inc. (NASDAQ:RXST) - MarketBeat
RxSight, Inc. (NASDAQ:RXST) Shares Bought by Barclays PLC - Defense World
MML Investors Services LLC Invests $452,000 in RxSight, Inc. (NASDAQ:RXST) - Defense World
RxSight (NASDAQ:RXST) Cut to Hold at Stifel Nicolaus - Defense World
RxSight (NASDAQ:RXST) Sets New 12-Month Low – What’s Next? - Defense World
RxSight, Inc. (NASDAQ:RXST) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
RxSight, Inc. (NASDAQ:RXST) Shares Bought by State Street Corp - MarketBeat
RxSight cut to hold at Stifel on competition concerns - MSN
RxSight stock touches 52-week low at $34.68 amid market shifts - Investing.com Australia
Stifel Downgrades RxSight (RXST) - MSN
Midday Stock Roundup: Mullen Down 10% Since Last Week’s Sales Update - Orange County Business Journal
RxSight Enters Oversold Territory (RXST) - Nasdaq
RxSight stock cut to hold at Stifel (RXST:NASDAQ) - Seeking Alpha
RxSight (NASDAQ:RXST) Reaches New 52-Week LowShould You Sell? - MarketBeat
RxSight stock touches 52-week low at $34.68 amid market shifts By Investing.com - Investing.com South Africa
Do You Believe in the Long-Term Growth Potential of RxSight (RXST)? - Insider Monkey
Forecasting The Future: 4 Analyst Projections For RxSight - Benzinga
Positive week for RxSight, Inc. (NASDAQ:RXST) institutional investors who lost 1.6% over the past year - Yahoo Finance
HighTower Advisors LLC Purchases 3,571 Shares of RxSight, Inc. (NASDAQ:RXST) - Defense World
Stifel downgrades RxSight stock on slowing LAL adoption projections - Investing.com
Stifel Downgrades RxSight Inc. (RXST) to Hold - StreetInsider.com
RxSight (NASDAQ:RXST) Trading Down 0.7%What's Next? - MarketBeat
RxSight (NASDAQ:RXST) Trading 3.7% HigherWhat's Next? - MarketBeat
RxSight, Inc. (NASDAQ:RXST) Shares Sold by Lord Abbett & CO. LLC - MarketBeat
RxSight (NASDAQ:RXST) Stock Price Up 1.3%Should You Buy? - MarketBeat
RxSight (NASDAQ:RXST) Trading Down 1.6%Here's Why - MarketBeat
RxSight (NASDAQ:RXST) Trading Down 4.8%Should You Sell? - MarketBeat
Wells Fargo cuts RxSight rating, sees limited growth potential By Investing.com - Investing.com Nigeria
RxSight (NASDAQ:RXST) Shares Gap DownHere's Why - MarketBeat
Wells Fargo cuts RxSight rating, sees limited growth potential - Investing.com
RxSight (NASDAQ:RXST) Given "Equal Weight" Rating at Wells Fargo & Company - MarketBeat
RxSight downgraded to Equal Weight from Overweight at Wells Fargo - TipRanks
RxSight (NASDAQ:RXST) Trading Down 1.9%Here's What Happened - MarketBeat
Two Sigma Advisers LP Sells 119,200 Shares of RxSight, Inc. (NASDAQ:RXST) - MarketBeat
RxSight (NASDAQ:RXST) Trading Down 0.1%What's Next? - MarketBeat
Charles Schwab Investment Management Inc. Acquires 62,507 Shares of RxSight, Inc. (NASDAQ:RXST) - MarketBeat
RxSight (NASDAQ:RXST) Research Coverage Started at UBS Group - Defense World
RxSight, Inc. (NASDAQ:RXST) Shares Sold by Fmr LLC - MarketBeat
RxSight (NASDAQ:RXST) Stock Price Down 2%Time to Sell? - MarketBeat
UBS Initiates Coverage of RxSight (RXST) with Buy Recommendation - Nasdaq
UBS bullish on RxSight stock, projects 20%+ sales growth through 2028 - Investing.com Nigeria
RxSight Inc (RXST) Stock Price Up 3.84% on Dec 6 - GuruFocus.com
RxSight (NASDAQ:RXST) Coverage Initiated at UBS Group - MarketBeat
Rxsight Inc Azioni (RXST) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):